Questionable Relation of Aryl Hydrocarbon Hydroxylase to Lung-Cancer Risk

Beverly Paigen(Jackson Laboratory), Nancy Thompson Hayner(Roswell Park Comprehensive Cancer Center), Lorne Houten(Roswell Park Comprehensive Cancer Center), Kenneth Paigen(Jackson Laboratory), Elizabeth Ward(American Cancer Society), Ronald G. Vincent(Roswell Park Comprehensive Cancer Center), Hira L. Gurtoo(Roswell Park Comprehensive Cancer Center), Natalie B. Parker(University of Colorado Cancer Center), Jun Minowada(Roswell Park Comprehensive Cancer Center)
New England Journal of Medicine
August 18, 1977
10.1056/nejm197708182970702
Cited by 137

Related Papers

Cancer treatment and survivorship statistics, 2012
|CA A Cancer Journal for Clinicians|2012|2.9k
Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer
|Cancer|2013|1.3k
The Collaborative Cross, a community resource for the genetic analysis of complex traits
|Nature Genetics|2004|1.2k
Annual Report to the Nation on the Status of Cancer, 1975–2002, Featuring Population-Based Trends in Cancer Treatment
|JNCI Journal of the National Cancer Institute|2005|954
Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.
|PubMed|1972|650